Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Opel N, Hanssen R, Steinmann LA, et al
Additionally, in the trial examining alcohol use disorder, a significant reduction in alcohol consumption was observed only in a specific subgroup of patients with obesity, suggesting that patient characteristics, such as BMI, might influence treatment outcomes
In one study, women lost an average of 14% of their body weight , while men lost around 8%
Your provider controls the schedule
The relationship between dose and metabolic response is not perfectly linear, which is why tirzepatide onset timing varies between individuals
For comparison with other weight loss injectable products: Mounjaro : 20.5% mean weight loss after 48 weeks (estimated from 72 week data) Wegovy (2.4 mg) : 15% mean weight loss after 48 weeks (estimated from 72 week data) Wegovy (7.2 mg) : 18% mean weight loss after 48 weeks (estimated from 72 week data) Therefore, Retatrutide currently shows the most significant weight-loss potential of any GLP-1based drug studied to date
US$ 21.60
US$ 26.33
US$ 28.63
US$ 25.39
